| Name | Craneware |
|---|---|
| Epic | CRW |
| Isin | GB00B2425G68 |
| Index | UK250 UK350 |
| Industry | Medical Equipment and Services |
| Latest share price | 2,040.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £722.34 | Debt ratio | n/a |
| Shares in issue | 35.41 | Debt-to-equity ratio | n/a |
| P/E ratio | 31 | Assets / equity ratio | n/a |
| Total dividends per share | 29.00p | Price to book value | n/a |
| Dividend yield | 1 | ROCE | -516.19 |
| Dividend cover | 3.27 | EPS growth | 9 |
| Earning per share | 33.5 | 52-week high / low | 1,700.00p / 2,470.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-11-28 | 2024-12-18 | 16.00p |
| Interim | 2024-03-21 | 2024-04-15 | 13.00p |
| Final | 2023-11-23 | 2023-12-15 | 16.00p |
| Interim | 2023-03-23 | 2023-04-14 | 12.50p |
| Final | 2022-11-24 | 2022-12-16 | 15.50p |
| Interim | 2022-03-24 | 2022-04-14 | 12.50p |
| Final | 2021-11-25 | 2021-12-21 | 15.50p |
| Interim | 2021-03-18 | 2021-04-15 | 12.00p |
| Final | 2020-11-19 | 2020-12-15 | 15.00p |
| Company name | Craneware |
|---|---|
| Address | 1 Tanfield Edinburgh, Scotland, United Kingdom, EH3 5DA |
| Telephone | +44 [0] 131 550 3100 |
| Website | http://www.craneware.com |
| Director | Position |
|---|---|
| Mr Keith Neilson | CEO |
| Mr Will Whitehorn | Non-Executive Chairman |
| Ms Isabel Urquhart | Chief Human Resources Officer |
| Ms Anne McCune | Independent Non-Executive Director |
| Mr Alistair Erskine | Independent Non-Executive Director |
| Mr David Kemp | Independent Non-Executive Director |
| Mr Craig Preston | CFO and Company Secretary |
| Assets $ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 30/06/24 | 30/06/23 | 30/06/22 |
| Intangible asssets and goodwill | 437.47 | 451.79 | 465.92 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 450.43 | 463.02 | 477.98 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 58.64 | 35.42 | 39.58 |
| Cash and equivalents | 34.59 | 78.54 | 47.16 |
| Other current assets and asset held for resale | n/a | n/a | 1.25 |
| Total of all assets | 543.66 | 576.98 | 565.97 |
| Liabilities $ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 66.3 | 121.76 | 78.08 |
| Long term liabilities | 148.76 | 127.38 | 154.86 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 215.06 | 249.13 | 232.95 |
| Net assets $ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 328.59 | 327.84 | 333.02 |
| Equity $ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 0.66 | 0.66 | 0.66 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 39.34 | 39.88 | 42.24 |
| Share premium account | 97.2 | 97.2 | 97.2 |
| Total equity | 328.59 | 327.84 | 333.02 |
| Income $ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 19.73 | 19.23 | 18.13 |
| Pre-tax profit | 15.75 | 13.09 | 13.1 |